{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:45:04Z","timestamp":1790477104445,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011392","name":"State Key Laboratory of Supramolecular Structure and Materials","doi-asserted-by":"publisher","award":["sklssm2024015"],"award-info":[{"award-number":["sklssm2024015"]}],"id":[{"id":"10.13039\/501100011392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2023-SJKF-003"],"award-info":[{"award-number":["2023-SJKF-003"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2023BAND02"],"award-info":[{"award-number":["2023BAND02"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003410","name":"Fujian Provincial Department of Education","doi-asserted-by":"publisher","award":["JZ240024"],"award-info":[{"award-number":["JZ240024"]}],"id":[{"id":"10.13039\/501100003410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021J02032"],"award-info":[{"award-number":["2021J02032"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024J01509"],"award-info":[{"award-number":["2024J01509"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2023Y9284"],"award-info":[{"award-number":["2023Y9284"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.phrs.2025.107834","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T19:01:31Z","timestamp":1750359691000},"page":"107834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy"],"prefix":"10.1016","volume":"218","author":[{"given":"Xueyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiexin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiewei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feisheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Cheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107834_bib1","doi-asserted-by":"crossref","DOI":"10.4103\/NRR.NRR-D-23-01890","article-title":"The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"20","author":"Liu","year":"2025","journal-title":"Neural Regeneration Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2313682","article-title":"Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer\u2019s disease","volume":"39","author":"Yu","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107834_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia","author":"Haney","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib4","article-title":"Metabolic phenotyping reveals an emerging role of ammonia abnormality in Alzheimer\u2019s disease","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib5","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2025.107834_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092587","article-title":"NF-\u03baB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer\u2019s Disease","volume":"11","author":"Sivamaruthi","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.phrs.2025.107834_bib7","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1007\/s12035-021-02661-x","article-title":"Microglia in Alzheimer\u2019s Disease: An Unprecedented Opportunity as Prospective Drug Target","volume":"59","author":"Kulkarni","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107834_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115120","article-title":"Novel neuroprotective pyromeconic acid derivatives with concurrent anti-A\u03b2 deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease","volume":"248","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib9","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1038\/s41467-022-35334-x","article-title":"Intracellular galectin-3 is a lipopolysaccharide sensor that promotes glycolysis through mTORC1 activation","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.phrs.2025.107834_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113047","article-title":"Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases","volume":"10","author":"Soares","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107834_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.649854","article-title":"Notch1 and Galectin-3 Modulate Cortical Reactive Astrocyte Response After Brain Injury","volume":"9","author":"Ribeiro","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107834_bib12","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1021\/acs.jmedchem.0c02001","article-title":"Synthesis, Structure\u2013Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors","volume":"64","author":"Xu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2025.107834_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbi.2019.01.019","article-title":"The role of galectin-3 in modulation of anxiety state level in mice","volume":"78","author":"Stajic","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib14","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","article-title":"Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease","volume":"10","author":"Siew","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep41689","article-title":"Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration","volume":"7","author":"Yip","year":"2017","journal-title":"Sci. Rep."},{"issue":"25","key":"10.1016\/j.phrs.2025.107834_bib16","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1523\/JNEUROSCI.2312-22.2023","article-title":"Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration","volume":"43","author":"Xue","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107834_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123085","article-title":"Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates A\u03b2 pathogenesis-induced neuroinflammation in 5 \u00d7 FAD mice","volume":"357","author":"Liu","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-023-00338-0","article-title":"Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer\u2019s disease","volume":"12","author":"Arroyo-Garc\u00eda","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13578-021-00592-7","article-title":"Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease","volume":"11","author":"Tan","year":"2021","journal-title":"Cell Biosci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107834_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41419-022-05058-3","article-title":"Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration","volume":"13","author":"Garcia-Revilla","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.107834_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bbi.2024.01.002","article-title":"Injured sensory neurons-derived galectin-3 contributes to neuropathic pain via programming microglia in the spinal dorsal horn","volume":"117","author":"Shan","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.phrs.2025.107834_bib22","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/acsmedchemlett.0c00330","article-title":"Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling","volume":"11","author":"Gabr","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.phrs.2025.107834_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","article-title":"Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease","volume":"138","author":"Boza-Serrano","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107834_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwad303","article-title":"AI enhances drug discovery and development","volume":"11","author":"Bai","year":"2024","journal-title":"Natl. Sci. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2025.107834_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/d41573-022-00025-1","article-title":"AI in small-molecule drug discovery: a coming wave?","volume":"21","author":"Jayatunga","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2025.107834_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-pharmtox-040323-040828","article-title":"Artificial Intelligence for Drug Discovery: Are We There Yet?","volume":"64","author":"Hasselgren","year":"2024","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.phrs.2025.107834_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eng.2023.01.014","article-title":"Artificial Intelligence in Pharmaceutical Sciences","volume":"27","author":"Lu","year":"2023","journal-title":"Engineering"},{"issue":"4","key":"10.1016\/j.phrs.2025.107834_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.drudis.2021.11.023","article-title":"Enhancing preclinical drug discovery with artificial intelligence","volume":"27","author":"Vijayan","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"6637","key":"10.1016\/j.phrs.2025.107834_bib29","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib30","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1038\/s41467-023-39856-w","article-title":"Sequence-based drug design as a concept in computational drug design","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107834_bib31","unstructured":"Touvron H., Martin L., Stone K.R., Albert P., Almahairi A., Babaei Y., Bashlykov N., Batra S., Bhargava P., Bhosale S., Bikel D.M., Blecher L., Ferrer C.C., Chen M., Cucurull G., Esiobu D., Fernandes J., Fu J., Fu W., Fuller B., Gao C., Goswami V., Goyal N., Hartshorn A.S., Hosseini S., Hou R., Inan H., Kardas M., Kerkez V., Khabsa M., Kloumann I.M., Korenev A.V., Koura P.S., Lachaux M.-A., Lavril T., Lee J., Liskovich D., Lu Y., Mao Y., Martinet X., Mihaylov T., Mishra P., Molybog I., Nie Y., Poulton A., Reizenstein J., Rungta R., Saladi K., Schelten A., Silva R., Smith E.M., Subramanian R., Tan X., Tang B., Taylor R., Williams A., Kuan J.X., Xu P., Yan Z., Zarov I., Zhang Y., Fan A., Kambadur M., Narang S., Rodriguez A., Stojnic R., Edunov S., Scialom T. Llama 2: open foundation and fine-tuned chat models. ArXiv. 2023;abs\/2307.09288."},{"issue":"12","key":"10.1016\/j.phrs.2025.107834_bib32","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/glia.22886","article-title":"Dual pathways mediate \u03b2-amyloid stimulated glutathione release from astrocytes","volume":"63","author":"Ye","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2025.107834_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108551","article-title":"A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy","volume":"161","author":"Liu","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"40","key":"10.1016\/j.phrs.2025.107834_bib34","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0896-6273(00)00084-2","article-title":"Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP","volume":"28","author":"Feng RHM","year":"2000","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13321-022-00619-2","article-title":"Blood-brain barrier penetration prediction enhanced by uncertainty estimation","volume":"14","author":"Tong","year":"2022","journal-title":"J. Chemin.."},{"issue":"12","key":"10.1016\/j.phrs.2025.107834_bib37","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1021\/acs.jcim.3c00150","article-title":"A Computational Physics-based Approach to Predict Unbound Brain-to-Plasma Partition Coefficient, Kp,uu","volume":"63","author":"Lawrenz","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"16","key":"10.1016\/j.phrs.2025.107834_bib38","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.1021\/acs.jmedchem.2c00517","article-title":"Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3","volume":"65","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2025.107834_bib39","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/med.21784","article-title":"Microglia-derived galectin-3 in neuroinflammation; a bittersweet ligand?","volume":"41","author":"Rahimian","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2025.107834_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105013","article-title":"N-Propargylamine-hydroxypyridinone hybrids as multitarget agents for the treatment of Alzheimer\u2019s disease","volume":"113","author":"Guo","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2025.107834_bib41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"GT. High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Kerns","year":"2003","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2025.107834_bib42","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/alz.13536","article-title":"Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity","volume":"20","author":"Borrego\u2013\u00c9cija","year":"2023","journal-title":"Alzheimer'S. Dement."},{"issue":"5","key":"10.1016\/j.phrs.2025.107834_bib43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00401-022-02469-6","article-title":"Galectin-3 is elevated in CSF and is associated with Abeta deposits and tau aggregates in brain tissue in Alzheimer's disease","volume":"144","author":"Boza-Serrano","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2025.107834_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.923811","article-title":"Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations","volume":"16","author":"Mijailovi\u0107","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"6637","key":"10.1016\/j.phrs.2025.107834_bib45","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.phrs.2025.107834_bib46","first-page":"2077","article-title":"Galectin-3 induces cell migration via a calcium-sensitive MAPK\/ERK1\/2 pathway","volume":"30","author":"Xiaoge Gao","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2025.107834_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175360","article-title":"Hippocampal Galectin-3 knockdown alleviates lipopolysaccharide-induced neurotoxicity and cognitive deficits by inhibiting TLR4\/NF-\u043aB signaling in aged mice","volume":"936","author":"Chen","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107834_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.npep.2019.02.001","article-title":"Neuroinflammation induced by the peptide amyloid-\u03b2 (25\u201335) increase the presence of galectin-3 in astrocytes and microglia and impairs spatial memory","volume":"74","author":"Ram\u00edrez","year":"2019","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.phrs.2025.107834_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41418-019-0348-z","article-title":"Galectin-3 promotes Abeta oligomerization and Abeta toxicity in a mouse model of Alzheimer's disease","volume":"27","author":"Tao","year":"2020","journal-title":"Cell Death Differ."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:44:11Z","timestamp":1762353851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825002592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":49,"alternative-id":["S1043661825002592"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107834","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107834"}}